Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Himanshu Nagar

GU Rad Onc · MSK

View

Dr. James Janopaul-Naylor

GU Rad Onc · MSK

View

Dr. Drew Moghanaki

Thoracic Rad Onc · UCLA

View

Dr. Michael Dykstra

General Rad Onc · UM

View

Dr. Lori Pierce

Breast Rad Onc · UM

View

Dr. William Hwang

GI Rad Onc · MGH

View

Dr. Kamran Ahmed

Breast Rad Onc · Moffitt Cancer Center

View

Dr. Philip Schauer

Bariatric Surgery · PBRC

View

Dr. Justin Hovey, FAAP, FACP, DABOM

Obesity Medicine · Noland Hospital Dothan II

View

Dr. Kimberly Gudzune

Obesity Medicine · JHU

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    DSDr. Daniel Spratt

    Dr. Daniel Spratt

    Radiation Oncology · Genitourinary Radiation Oncology
    Case Western Reserve University
    danielspratt

    Research

    Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III Trials

    2025

    Via Journal of Clinical Oncology

    Research

    Time to Treatment Initiation for the 30 Most Prevalent Cancer Types: Trends and Predictors of Change

    2025

    Via JCO Oncology Practice

    Research

    Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data

    2025

    Via European Urology

    Research

    Digital pathology biomarkers for guiding radiotherapy-based treatment concepts in prostate cancer — a systematic review and expert consensus

    2025

    Via Radiotherapy and Oncology

    Research

    Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial

    2025

    Via European Urology Oncology

    Research

    Radiotherapy- Versus Surgery-based Treatment Strategy in High-risk Prostate Cancer

    2025

    Via European Urology Oncology

    Research

    Phase 3 Trial of Dose-Escalated Radiation Therapy and Standard Androgen Deprivation Therapy Versus Dose-Escalated Radiation Therapy and Enhanced Androgen Deprivation Therapy With Orteronel for Men With High-Risk Prostate Cancer (NRG/RTOG 1115)

    2025

    Via International Journal of Radiation Oncology, Biology, Physics

    Research

    Statin Use in Patients With Advanced Prostate Cancer in the TITAN and SPARTAN Trials

    2025

    Via JAMA Network Open

    Research

    Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers

    2025

    Via Cell

    Research

    Individual income and race-associated differences in prostate cancer mortality in a statewide registry

    2025

    Via JNCI Cancer Spectrum

    Research

    Revisiting prostate cancer active surveillance candidacy

    2025

    Via The Lancet Oncology

    Research

    Age and Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer

    2025

    Via NEJM Evidence

    Research

    Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology

    2025

    Via Journal of the National Comprehensive Cancer Network

    Research

    Heart Disease Mortality After Primary Cancer Surgery in the United States

    2025

    Via American Journal of Clinical Oncology